{"id":432428,"title":"Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Sex Differences - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-02","captureTimestamp":"2026-01-02T08:02:43.945000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/considerations-inclusion-women-clinical-trials-analysis-data-sex-differences.html","snippet":"Guidance Document: Considerations for Inclusion of Women in Clinical Trials and Analysis of Sex Differences Date May 29, 2013 Foreword Guidance documents are meant to provide assistance to industry and health care professionals on how to comply with governing statutes and…","rawSnapshotUrl":"/api/snapshots/raw/432428","browseUrl":"https://replay.healtharchive.ca/job-6/20260102080243/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/considerations-inclusion-women-clinical-trials-analysis-data-sex-differences.html#ha_snapshot=432428","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}